相似文献
1
Seronegative spondyloarthropathies: to lump or split?
Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii9-13. doi: 10.1136/ard.2004.033654.
2
Relationship of Psoriatic Arthritis to Other Spondyloarthritides.
J Rheumatol Suppl. 2015 Nov;93:33-5. doi: 10.3899/jrheum.150632.
3
Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis.
Rheumatol Int. 2009 Feb;29(4):365-70. doi: 10.1007/s00296-008-0692-7. Epub 2008 Sep 3.
4
Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis.
Rheumatol Int. 2008 Aug;28(10):959-64. doi: 10.1007/s00296-008-0553-4. Epub 2008 Mar 4.
5
The Seronegative Spondyloarthropathies.
Prim Care. 2018 Jun;45(2):271-287. doi: 10.1016/j.pop.2018.02.005.
6
Ocular features of the HLA-B27-positive seronegative spondyloarthropathies.
Curr Opin Ophthalmol. 2018 Nov;29(6):552-557. doi: 10.1097/ICU.0000000000000525.
7
Classification criteria: peripheral spondyloarthropathy and psoriatic arthritis.
Curr Rheumatol Rep. 2013 Apr;15(4):317. doi: 10.1007/s11926-013-0317-3.
8
Relationship of psoriatic arthritis with the other spondyloarthropathies.
Curr Opin Rheumatol. 2004 Jul;16(4):344-9. doi: 10.1097/01.bor.0000129717.19777.9d.
9
[Extraskeletal manifestations of seronegative spondyloarthropathies].
Reumatizam. 2004;51(2):19-21.
10
[Spondyloarthropathies in childhood].
Pol Merkur Lekarski. 2004 Jul;17(97):76-80.
引用本文的文献
1
[Spondylitis and spondylodiscitis].
Radiologie (Heidelb). 2025 Jun 25. doi: 10.1007/s00117-025-01478-2.
2
Peripheral spondyloarthritis and psoriatic arthritis : are we dealing with semantics or clinically meaningful differences?
RMD Open. 2022 Nov;8(2). doi: 10.1136/rmdopen-2022-002592.
3
New Insights into the Regulatory Role of Ferroptosis in Ankylosing Spondylitis via Consensus Clustering of Ferroptosis-Related Genes and Weighted Gene Co-Expression Network Analysis.
Genes (Basel). 2022 Jul 31;13(8):1373. doi: 10.3390/genes13081373.
4
[History of reactive arthritis. Historical milestones and future].
Z Rheumatol. 2022 Oct;81(8):692-698. doi: 10.1007/s00393-022-01253-x. Epub 2022 Aug 25.
5
Axial spondyloarthritis: concept, construct, classification and implications for therapy.
Nat Rev Rheumatol. 2021 Feb;17(2):109-118. doi: 10.1038/s41584-020-00552-4. Epub 2020 Dec 23.
6
Classification and Outcome Measures for Psoriatic Arthritis.
Front Med (Lausanne). 2018 Sep 6;5:246. doi: 10.3389/fmed.2018.00246. eCollection 2018.
7
Higher Levels of Secretory IgA Are Associated with Low Disease Activity Index in Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis.
Front Immunol. 2017 Apr 27;8:476. doi: 10.3389/fimmu.2017.00476. eCollection 2017.
8
Effect of ethnicity on disease activity and physical function in psoriatic arthritis in a multiethnic Asian population.
Clin Rheumatol. 2017 Jan;36(1):125-131. doi: 10.1007/s10067-016-3460-1. Epub 2016 Oct 30.
9
Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis.
Auto Immun Highlights. 2013 Feb 22;4(3):87-94. doi: 10.1007/s13317-013-0049-4. eCollection 2013 Dec.
10
Clinical value of whole-body PET/CT in patients with active rheumatic diseases.
Arthritis Res Ther. 2014;16(5):423. doi: 10.1186/s13075-014-0423-2.
本文引用的文献
1
Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.
Arthritis Rheum. 2004 Jul;50(7):2264-72. doi: 10.1002/art.20335.
2
Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?
Arthritis Rheum. 2004 Jun 15;51(3):311-5. doi: 10.1002/art.20421.
3
The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index.
Arthritis Rheum. 2004 Apr 15;51(2):154-9. doi: 10.1002/art.20233.
4
Genetic susceptibility to ankylosing spondylitis.
Curr Mol Med. 2004 Feb;4(1):13-20. doi: 10.2174/1566524043479284.
5
Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis.
Ann Rheum Dis. 2004 Feb;63(2):162-9. doi: 10.1136/ard.2003.006296.
6
A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis--'DIP or not DIP revisited'.
Rheumatology (Oxford). 2003 Dec;42(12):1469-76. doi: 10.1093/rheumatology/keg445. Epub 2003 Jul 16.
7
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis.
Ann Rheum Dis. 2003 Jan;62(1):20-6. doi: 10.1136/ard.62.1.20.
8
Ankylosing spondylitis: how should the disease be assessed?
Best Pract Res Clin Rheumatol. 2002 Sep;16(4):605-18. doi: 10.1053/berh.2002.0252.
9
Ankylosing spondylitis and bowel disease.
Best Pract Res Clin Rheumatol. 2002 Sep;16(4):537-49. doi: 10.1053/berh.2002.0249.
10
Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18-19 January 2002.
Ann Rheum Dis. 2002 Dec;61 Suppl 3(Suppl 3):iii61-7. doi: 10.1136/ard.61.suppl_3.iii61.
Zotero 插件